|
PHARMA
RESEARCH CONFLUENCE
|
EDIT
|
Pharma
World 2005 |
Editorial
Painful painkillers
Edit Article
Clinical trials:
Will the boom sustain?
|
|
SPONSORS
|
CLINICAL
RESEARCH & GCP WORKSHOP
|
|
Synchron:
Leading in clinical trials and medical research services
Thermo
Electron Corporation: Innovative technology leader
|
GCP
review and quiz
Protocol
group exercise
Importance
of chirality in drug discovery
Informed
consent process
|
|
PRE-CLINICAL
RESEARCH
|
PRE-CLINICAL
RESEARCH SEMINAR
|
|
IPR
mediated opportunities in the pharma industry
The
role of chemical development in drug development
Role
of pharmacokinetics in drug discovery & development
Target
selection in drug discovery
|
Preclinical
toxicology evaluation
Risk
management and insurance solutions in the Indian pharma
industry
|
|
OPED
|
CORPORATE
|
|
Pre-clinical
contract research A market awaiting India
|
Galpha
Labs to set up unit in Baddi
Strides,
Stada conclude development and supply agreement for
US
Avesthagen
appoints new business heads
Biocon
says oral insulin may become blockbuster
|
|
TECHNOLOGY TRENDZ
|
HAPPENINGS
|
|
Intelligent
Drug Delivery Technologies: An outlook
Currently, the focus has been on novel or innovative
drug delivery technologies that are intelligent enough
to navigate the therapeutic molecule to the desired
site, quickly and economically, say Vivek Ranjan Sinha,
Jayant Rajaram Bhinge and Aman Trehan
|
AIDCOC,
Millipore organise workshop on web and aseptic processing
IIPS
workshop on intl drug regulatory affairs in April
Book
titled Scientific Foundation of Ayurveda unveiled
|
|
MARKETPLACE
|
HEALTH
NEWS
|
|
Changing
role of managers while jointly working with MRs
R K Srivastava reviews activities in the current scenario
and also suggests various steps a manager should take
while working jointly with medical representatives
|
Is India
prepared for global medical tourism boom?
In recent years, India is being seen as an important
player in the globally growing "Medical Tourism",
which is projected as a new segment in travel and healthcare
business. The former Indian finance minister Jaswant
Singh envisaged to make India a "Global health
destination" and the budget tabled by him included
government policy for collaboration between the available
medical expertise in the country and tourism industry.
|
|
IN
THE NEWS
|
TRIPs
|
|
USP to
establish site in India
Let quality
be permeated, not controlled: Ace BioMed
|
TRIPs impact
on R&D: Facts, facets and implications for Indian
pharma industry
The post-TRIPs scenario offers a viable option in terms
of partnerships with MNCs, which indigenous firms need
to capitalise upon, say Mohd. Arif Khan, Imran Parvez,
Anand Sharma and Parikshit Bansal
|
|
NANOTECH
|
NDDS
|
|
Nanosuspension
drug delivery: Technology and application
Poorly soluble and low bioavailablity drugs so called
brick dust candidates once abandoned from
formulation development work can be rescued with nanosuspension
technology says Kirupakar B R
|
Biotin binding
proteins: Concepts and role in targeted drug delivery
Drug targeting using biotin binding proteins may hold
the answer for drugs which have not been able to show
their effects because they cannot gather in effective
concentrations at the target, say Aditya Pattani and
Manan Desai
|
|
CONVERSATION
|
|
GCP
culture is the key to success in clinical research
Brijesh Regal, the founder CEO of Apothecaries
Limited and an M Pharm from Delhi University, has vast
experience of organising clinical trials in various
therapeutic areas for some of the major global pharmaceutical
giants. In an exclusive interview, Regal tells Jayashree
Padmini that quality is a non-negotiable issue in clinical
research. Excerpts:
|